/Investor DB

Boutique Venture Partners — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Filtricine, Inc.filtricine.comin𝕏Aug 2021

Filtricine is a clinical-stage biotechnology company developing nutrition-based medical food products for disease control, using its Targeted Nutrients Deprivation (TND) approach to starve cancer cells while providing balanced nutrition to patients.

BiotechDigital HealthFoodTechSan Francisco Bay Area, US

Co-investorsBluestein VenturesEvolution VC PartnersSand Hill AngelsSOSVStartXTrue Ventures

NERvnervtechnologies.comApr 2021 · $2.6M

NERV builds industrial-grade sensor modules and a monitoring platform that provide real-time tracking, failure prediction, and automated compliance reporting for HVAC/R and cold-chain assets.

AI & Machine LearningIoTLogistics & Supply Chain

Co-investorsDorm RoomGraphene VenturesOneValleySOSVThreshold Impact

Sion Powersionpower.comNov 2021

Sion Power develops lithium-metal batteries through its patented Licerion platform, offering high energy-density cells for defense, aerospace, and electric vehicle applications.

CleantechEnergyNew MaterialsTucson, US

MARK SMITH(Chief Financial Officer)Pamela Fletcher(CEO)inMitch Hourtienne(Chief Commercial Officer)inTracy Kelley(President & Chief Science Officer)Job Rijssenbeek(CTO)DENNIS R. MANGINO(Director)

Co-investorsLG Technology Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.